• 1. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 2. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 3. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 4. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 5. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Trifluoromethylbenzenes

Comprehensive Overview of (2-{2-4-(Trifluoromethyl)phenyl-1,3-thiazol-4-yl}Ethyl)amine Dihydrochloride (CAS No. 1332531-22-2)

The compound (2-{2-4-(Trifluoromethyl)phenyl-1,3-thiazol-4-yl}Ethyl)amine Dihydrochloride (CAS No. 1332531-22-2) is a specialized organic molecule with significant potential in pharmaceutical and agrochemical research. Its unique structure, featuring a thiazole ring and a trifluoromethylphenyl group, makes it a valuable intermediate for drug discovery and material science applications. Researchers are increasingly interested in this compound due to its role in modulating biological pathways, particularly in the development of small-molecule inhibitors and bioactive probes.

In recent years, the demand for fluorinated compounds like (2-{2-4-(Trifluoromethyl)phenyl-1,3-thiazol-4-yl}Ethyl)amine Dihydrochloride has surged, driven by their enhanced metabolic stability and bioavailability. This aligns with the growing focus on precision medicine and targeted therapies, where such molecules are pivotal. The trifluoromethyl group, in particular, is a hotspot in medicinal chemistry due to its ability to improve lipophilicity and binding affinity, making it a key feature in modern drug design.

From a synthetic perspective, CAS No. 1332531-22-2 is often utilized in heterocyclic chemistry and peptide coupling reactions. Its amine functionality allows for further derivatization, enabling the creation of diverse molecular libraries for high-throughput screening. This versatility has made it a sought-after reagent in combinatorial chemistry and fragment-based drug discovery, addressing the need for novel scaffolds in therapeutic development.

Environmental and regulatory considerations also play a role in the compound's applications. With the rise of green chemistry initiatives, researchers are exploring sustainable synthesis routes for thiazole derivatives like this one. Its dihydrochloride salt form enhances solubility, reducing the need for hazardous solvents—a critical factor in lab safety and waste reduction strategies. These attributes align with the broader industry shift toward eco-friendly chemical processes.

In the context of AI-driven drug discovery, (2-{2-4-(Trifluoromethyl)phenyl-1,3-thiazol-4-yl}Ethyl)amine Dihydrochloride has garnered attention as a potential machine learning training dataset component. Computational models increasingly rely on structurally diverse compounds to predict bioactivity, and this molecule's unique features contribute to such datasets. This intersection of cheminformatics and artificial intelligence highlights its relevance in cutting-edge research.

For suppliers and manufacturers, ensuring high purity and consistent quality of CAS No. 1332531-22-2 is paramount. Analytical techniques like HPLC, NMR, and mass spectrometry are routinely employed to verify its specifications. The compound's stability under various storage conditions is another area of interest, particularly for long-term biobanking and pharmaceutical storage applications.

Looking ahead, the potential of (2-{2-4-(Trifluoromethyl)phenyl-1,3-thiazol-4-yl}Ethyl)amine Dihydrochloride extends to neurological research and infectious disease studies. Preliminary data suggest its utility in targeting enzyme inhibitors and receptor modulators, though further in vitro and in vivo validation is needed. As the scientific community continues to explore its applications, this compound remains a promising candidate for advancing translational medicine.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)